For eligible subcapsular PTMC patients, TA achieves 4-year clinical outcomes comparable to those of intraparenchymal PTMC cases, warranting further prospective investigations.
Jing et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: